Although the detailed mechanism on how the NOX inhibitor enhances the level of OCR remains to be elucidated, this approach can be effective in reducing or preventing the accumulation of typical PD-related biomarkers, such as protein aggregates, phosphor-α-syn and mitochondrial dysfunctions [26,38,41,43]. The gene discussed is SPIN1; the disease is Parkinson disease.